FDA-cleared AI-powered ECG devices and enterprise cardiac monitoring platform
AliveCor builds FDA-cleared ECG hardware and a cloud platform for cardiac arrhythmia detection, now integrating AI into both consumer and clinician-facing applications. The stack is containerized and cloud-native (Go, Kubernetes, AWS, PostgreSQL, Redis, DynamoDB), with active pain points around microservice concurrency and backend optimization—suggesting the platform is handling real-time patient data at scale. Hiring is accelerating across engineering and marketing, with a focus on enterprise healthcare systems and international expansion.
AliveCor develops personal ECG devices and an enterprise platform for cardiac monitoring and atrial fibrillation detection. The flagship KardiaMobile hardware is FDA-cleared and clinically validated; the Kardia platform enables third-party providers—healthcare systems, telehealth networks, and direct consumers—to monitor and manage heart conditions with AI-assisted diagnosis. The company operates across three commercial channels: direct-to-consumer sales, enterprise partnerships with healthcare providers, and international expansion (including Amazon EU). AliveCor maintains HIPAA compliance, SOC 2 Type 2, and ISO 27001 certifications to meet healthcare data security requirements.
Go, Java, Kubernetes, AWS, PostgreSQL, Redis, DynamoDB, Ruby on Rails, React, Python, iOS, and Android. Testing and API tools include Selenium, Appium, REST Assured, and Postman.
Mountain View, California. The company was founded in 2010 and is privately held, with 51–200 employees. Hiring spans the United States and India.
Other companies in the same industry, closest in size
AliveCor's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.